Why it was included in the FDA ban The FDA cites risk for immunogenicity, peptide-related impurities, and limited safety-related information as reasons for the BPC-157 ban
At Intra-V, we offer medically supervised peptide therapy, including BPC-157, to support the body's natural healing and repair processes
How long should a BPC-157 dosing cycle last before stopping
Journal Of Biomolecular Structure & Dynamics, 42 (10), 5015-5029
Downstream Cascade A NAD+ Salvage and SIRT1 Activation NNMT normally acts as a sink for nicotinamide, permanently removing it from the NAD+ salvage pathway by methylating it into 1-MNA (which is then excreted)
very friendly and efficient